Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer

NCT05299840 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
450
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Oncomedics

Collaborators